Mobile menu footer

Aug 6, 2020 | Uncategorized

Anocca AB

General enquires
info@anocca.com

Business Development & Partnering
bd@anocca.com

Science & Technology
sci@anocca.com

Visit us on LinkedIn

< Back to newsroom

Latest news

Press release Dec 21, 2022
Anocca säkrar 25 miljoner euro från Europeiska investeringsbanken (EIB) för att stödja klinisk utveckling av nästa generations T-cellsterapier för cancer
Södertälje, 21 december 2022 – Anocca, ett helt integrerat bioteknikföretag för utveckling av T-cellsbehandlingar, meddelade …

Read more »
Press release Dec 21, 2022
Anocca secures EUR 25 million from the European Investment Bank (EIB) to support clinical development of next-generation T-cell therapies for cancer
Södertälje, Sweden, 21 December 2022 – Anocca, a fully integrated cell therapy biotechnology company, today …

Read more »
Press release Apr 7, 2022
Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory Board
Södertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms …

Read more »